Results for tag: "Dyschromia Drug"

Dyschromia is a skin condition characterized by discoloration of the skin. Dyschromia drugs are used to treat this condition, and are a subset of dermatological drugs. Dyschromia drugs are typically topical medications, such as creams, ointments, and lotions, that are applied directly to the affected area. These drugs work by inhibiting the production of melanin, the pigment responsible for skin color. Dyschromia drugs can also be taken orally, such as pills or capsules. The dyschromia drug market is a rapidly growing segment of the dermatological drug market. This is due to the increasing prevalence of skin conditions, such as melasma, vitiligo, and post-inflammatory hyperpigmentation. As a result, there is a growing demand for effective treatments for these conditions. Some companies in the dyschromia drug market include Galderma, Allergan, and Sun Pharmaceuticals. These companies produce a variety of topical and oral medications for the treatment of dyschromia. Additionally, there are many smaller companies that specialize in the development and manufacture of dyschromia drugs. Show Less Read more